Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.

Whyte, M.P., Simmons, J.H., Moseley, S. et al. (7 more authors) (2018) Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes and Endocrinology. ISSN 2213-8587

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Elsevier. This is an author produced version of a paper subsequently published in The Lancet Diabetes and Endocrinology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Dates:
  • Accepted: 16 October 2018
  • Published (online): 14 December 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 03 Jan 2019 16:18
Last Modified: 14 Jun 2019 00:40
Published Version: https://doi.org/10.1016/S2213-8587(18)30307-3
Status: Published online
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/S2213-8587(18)30307-3
Related URLs:

Share / Export

Statistics